This 5-peptide fat loss cocktail isn't what it seems

What does Lars Langen actually claim here?

Langen lists five peptides he supposedly used together for "rapid fat loss": retatrutide at 1mg weekly, semaglutide at 0.5mg weekly, plus three research compounds (MOTS-c, AOD-9604, and cargrilintide) at various doses. He presents this as his personal protocol but adds an "educational purposes only" disclaimer.

This combination mixes two FDA-approved GLP-1 medications with experimental peptides that aren't approved for human use. The doses he lists for retatrutide and semaglutide are both above standard prescribing guidelines.

Do these peptides actually work for weight loss?

Retatrutide and semaglutide have solid clinical evidence, but the others don't. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed retatrutide at 15mg weekly led to 20.9% weight loss over 72 weeks. Semaglutide at 2.4mg weekly produced 14.9% weight loss in STEP 1 (Wilding et al., NEJM, 2021).

MOTS-c, AOD-9604, and cargrilintide have minimal human data. MOTS-c studies exist only in animals and small human pilot studies. AOD-9604 failed to show weight loss benefits in a 12-week randomized trial (Heffernan et al., 2001). Cargrilintide showed modest effects in early trials but never reached market approval.

What's wrong with this protocol?

First, combining two GLP-1 receptor agonists makes no pharmacological sense. Both retatrutide and semaglutide work through the same pathway, so stacking them just increases side effects without added benefits.

Second, the doses are off. Retatrutide trials used up to 12mg weekly, but Langen claims 1mg. Semaglutide for weight loss is typically 2.4mg weekly, not 0.5mg. These lower doses suggest he's either using different compounds or doesn't understand proper dosing.

Third, three of these five peptides aren't legally available for human use outside research settings. Presenting this as a real protocol misleads followers who can't actually replicate it.

What should you know about peptide weight loss?

Stick to what's actually proven and available. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have extensive clinical data showing 15-22% weight loss when properly dosed.

Research peptides sold online aren't regulated by the FDA. You don't know their purity, sterility, or actual contents. The MOTS-c or AOD-9604 you buy could be anything.

Real peptide therapy should involve proper medical supervision, not Instagram protocols. If you're interested in GLP-1 medications for weight loss, work with a qualified provider who can prescribe FDA-approved options and monitor your progress safely.